Sort   by:  
 Page size 
UnknownSpatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum.
Not available
S-EPMC7727356 | biostudies-literature
Unknown18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Not available
S-EPMC7719031 | biostudies-literature
UnknownImaging markers for Alzheimer disease: which vs how.
Not available
S-EPMC3776529 | biostudies-literature
UnknownEffect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Not available
S-EPMC4882617 | biostudies-literature
UnknownTau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.
Not available
S-EPMC12321570 | biostudies-literature
UnknownThe mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Not available
S-EPMC4262609 | biostudies-literature
UnknownVascular burden and Alzheimer disease pathologic progression.
Not available
S-EPMC3448744 | biostudies-literature
UnknownAmyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
Not available
S-EPMC4831042 | biostudies-literature
UnknownAssociation of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
Not available
S-EPMC5786156 | biostudies-literature
UnknownPrevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Not available
S-EPMC4486209 | biostudies-literature
Sort   by:  
 Page size